Skip to main content

Randomized Phase II trial study of lenalidomide, bortezomib and dexamethsone (RVD)with or without Panobinostat in new MM pts

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Novartis Pharmaceuticals Corporation

Start Date

September 1, 2016

End Date

October 24, 2017
 

Administered By

Duke Cancer Institute

Awarded By

Novartis Pharmaceuticals Corporation

Start Date

September 1, 2016

End Date

October 24, 2017